Alzinova Future Growth
Future criteria checks 3/6
Alzinova's earnings are forecast to decline at 39.4% per annum while its annual revenue is expected to grow at 17.7% per year. EPS is expected to decline by 13.3% per annum.
Key information
-39.4%
Earnings growth rate
-13.3%
EPS growth rate
| Biotechs earnings growth | 45.7% |
| Revenue growth rate | 17.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 12 | -48 | -84 | -62 | 2 |
| 12/31/2025 | 64 | 8 | -9 | 10 | 2 |
| 12/31/2024 | 7 | -20 | -34 | -19 | 2 |
| 9/30/2024 | 17 | -19 | -36 | -19 | N/A |
| 6/30/2024 | 15 | -18 | -32 | -17 | N/A |
| 3/31/2024 | 18 | -17 | -34 | -17 | N/A |
| 12/31/2023 | 20 | -16 | -35 | -15 | N/A |
| 9/30/2023 | 17 | -16 | -31 | -13 | N/A |
| 6/30/2023 | 17 | -16 | -32 | -15 | N/A |
| 3/31/2023 | 14 | -15 | -32 | -17 | N/A |
| 12/31/2022 | 17 | -13 | -27 | -10 | N/A |
| 9/30/2022 | 16 | -11 | -26 | -10 | N/A |
| 6/30/2022 | 15 | -9 | -27 | -12 | N/A |
| 3/31/2022 | 17 | -8 | -25 | -8 | N/A |
| 12/31/2021 | 17 | -8 | -27 | -10 | N/A |
| 9/30/2021 | 18 | -7 | -25 | -7 | N/A |
| 6/30/2021 | 19 | -7 | -24 | -5 | N/A |
| 3/31/2021 | 16 | -6 | -20 | -5 | N/A |
| 12/31/2020 | 15 | -6 | -21 | -6 | N/A |
| 9/30/2020 | 13 | -7 | -21 | -8 | N/A |
| 6/30/2020 | 12 | -6 | -18 | -7 | N/A |
| 3/31/2020 | 11 | -7 | -17 | -6 | N/A |
| 12/31/2019 | 7 | -6 | -11 | -4 | N/A |
| 9/30/2019 | 5 | -5 | -11 | -6 | N/A |
| 6/30/2019 | 6 | -5 | -11 | -5 | N/A |
| 3/31/2019 | 8 | -5 | -11 | -3 | N/A |
| 12/31/2018 | 9 | -4 | -13 | -4 | N/A |
| 9/30/2018 | 11 | -3 | -13 | -2 | N/A |
| 6/30/2018 | 10 | -3 | N/A | -2 | N/A |
| 3/31/2018 | 8 | -2 | N/A | -2 | N/A |
| 12/31/2017 | 6 | -3 | N/A | -2 | N/A |
| 9/30/2017 | 5 | -3 | N/A | -2 | N/A |
| 6/30/2017 | 4 | -3 | N/A | -3 | N/A |
| 3/31/2017 | 5 | -4 | N/A | -3 | N/A |
| 12/31/2016 | 5 | -3 | N/A | -3 | N/A |
| 9/30/2016 | 5 | -4 | N/A | -3 | N/A |
| 6/30/2016 | 4 | -4 | N/A | -3 | N/A |
| 3/31/2016 | 2 | -3 | N/A | -3 | N/A |
| 12/31/2015 | 1 | -3 | N/A | -3 | N/A |
| 12/31/2014 | 1 | 0 | N/A | -1 | N/A |
| 12/31/2013 | 1 | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALZ's earnings are forecast to decline over the next 3 years (-39.4% per year).
Earnings vs Market: ALZ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ALZ is expected to become profitable in the next 3 years.
Revenue vs Market: ALZ's revenue (17.7% per year) is forecast to grow faster than the Swedish market (-0% per year).
High Growth Revenue: ALZ's revenue (17.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALZ's Return on Equity is forecast to be high in 3 years time